SBI Securities’s Repare Therapeutics RPTX Stock Holding History

SBI Securities’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,252	Closed	-$3.25K	–	4134
2025 Q4	$3.25K	Sell	1,252 -10	-0.8%	-$20	﹤0.01%	2201
2025 Q3	$2.22K	Hold	1,262	–	–	﹤0.01%	2385
2025 Q2	$1.75K	Hold	1,262	–	–	﹤0.01%	2442
2025 Q1	$1.24K	Buy	1,262 +1,000	+382%	+$1.21K	﹤0.01%	2491
2024 Q4	$343	Buy	+262	New	+$780	﹤0.01%	3031

SBI Securities's RPTX Position: Q1 2026 in Review

SBI Securities sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 1,252 shares — an estimated $3.25K sold.

SBI Securities first reported a position in RPTX in Q4 2024 and held it in 5 quarters. The position peaked at $3.25K in Q4 2025. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

SBI Securities reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
SBI Securities sold 1,252 Repare Therapeutics shares in Q1 2026, an estimated $3.25K.
SBI Securities first reported a position in Repare Therapeutics in Q4 2024 and held it in 5 quarters.
SBI Securities's Repare Therapeutics position peaked at $3.25K in Q4 2025.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.